
Geron Corporation has announced that the US Food and Drug Administration (FDA) has approved Rytelo (imetelstat) for the treatment of …
Celerion has completed the acquisition of MDS Pharma Services’ early-stage development and regulatory services business, marking the latter’s exit from …
MDS has completed the sell-off of its contract research and development business – MDS Pharma Services – with the signing …

Canadian clinical research firm MDS has appointed Steve West chief executive. He was formerly president of MDS Nordion and chief …
Pharmafocus presents a round-up of developments in the contract research sector, including CBI's acquisition of a peptide specialist, MDS Pharma …
Canadian life sciences company MDS has offloaded part of its pharmaceutical services division to INC Research in a $50 million …

